z-logo
open-access-imgOpen Access
Anthracyclines for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Are We Ready to Let Them Go?
Author(s) -
Paolo Tarantino,
Sara M. Tolaney,
Nadia Harbeck,
Javier Cortés,
Giuseppe Curigliano
Publication year - 2021
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.21.01059
Subject(s) - medicine , human epidermal growth factor receptor 2 , breast cancer , epidermal growth factor receptor , oncology , cancer research , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom